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  Recurrence rate of the bladder tumor was studied on 132 patients who had non－infi！trating，
pedunculated tumor in the bladder and had neither treatment nor preventive measures since
the first surgery．
  ／） Average age of the patients Nvas 59．6 and the sex ratio was 3．4 （｝1vC［） ：1 （F）．
  2） The recurrence rate was 27．3％ within six rnonths， 43．5％ wkhin one ＞rear， 57．3％
wi亡hin two years and 92．7％wi亡hln最ve years．
  3） There was no sex difference in the rate．
  4） The recurrence rate within two years was 45％ in the single tumors whereas 78％
in the multiple tumors． The rate after this period showed no significant difference between
both groups．




























































































































Totai l io2 177．31 30 122．7［i32 1ioo．o
Youngest patient ： 25 year－old
Oldest patient ： 82 year－old
Average age ： 59．6yaers
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Table 3 Recurrences of bladder cancer
 during each observation period












1 ～2y 8／49 工6．3
2 ～3y 5／22 22．7
3 ～4y 3／10 30．0






        …～6m
27／102・26．5 9／30 30．0
～！y 37／83 44．6 10／25 40．0
～2y   I45／75 60．0 10／21 47．6
        1～3y  i
50／61 82．0 10／16 62．5
～4y l        l5！／56 91．1 12／王4 85．7
～5y  i5！／55 92．7 12／13 92．3
5y～  ｛           」
53／55 96．4 12／13 92．3
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Fig． 3 Sex and recurrences of the bladder tumors
Table 5 Multiplicity and recurrences
 of the bladder tumors
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～5y 32／36 88．9 31／32 96．9
5y～ 34／36】94．4 31／32 96．9
3）単発，多発と再発率
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 Fig． 4 Multiplicity and recurrences of the bladder tumors
Table 6 First treatment for ／32 cases
 of b工adder turnor



























．／／2 ／ 2 3 4 5 years
Fig． 5 First treatment and recurrences of bladder tumors
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Table 7 First treatment and recurrences of bladder tumors









FulgurationExcision of tumorsand fulgurationSegmental resection
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